Drug offers hope in treating ocular melanoma

Video

Richard Carvajal, MD, associate professor at Columbia University Medical Center, discusses one drug potential to treat ocular melanoma at ARVO 2018 in Honolulu.

The views expressed here belong to the author. They do not necessarily represent the views of Optometry Times or UBM Medica.

Richard Carvajal, MD, associate professor at Columbia University Medical Center, discusses one drug potential to treat ocular melanoma at ARVO 2018 in Honolulu.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Subscribe Now!
Recent Videos
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Rachelle Lin, OD, MS, FAAO
Rachelle Lin, OD, MS, FAAO, at CRU Eye Symposium 2025
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Dr. Julie Rodman discusses retina, imaging, and posterior segment in SECO presentations
Dr. Julie Rodman previews her SECO presentations
Sherrol Reynolds, OD, FAAO, values the ophthalmic-optometric collaboration on display at the summit, running from February 14-17, 2025 in San Juan, Puerto Rico.
Dr Carolyn Majcher chats about GA and posterior uveitis at AAOpt 2024
Dr. Mark Dunbar chats about his EyeCon 2024 presentation about diabetic eye care
Related Content
Pill being held between fingers Image credit: AdobeStock/DianaVyshniakova

Focus Vitamins expands portfolio with new Focus Lutein Capsules

Jordana Joy, Associate Editor
April 29th 2025
Article
Optometry Times You and Eye

You and Eye: What optometrists need to know about low vision

Miriam Korik, OD;Emily Kaiser Maharjan, Assistant Managing Editor
March 13th 2024
Podcast
Dr Neda Shamie highlights some of her most highly anticipated symposia from the upcoming Controversies in Modern Eye Care meeting.

Q&A: The education at the 19th Annual Controversies in Modern Eye Care is a force to be reckoned with

Neda Shamie, MD;Sheryl Stevenson, Eye Care Group Editorial Director;Emily Kaiser Maharjan, Assistant Managing Editor
April 22nd 2025
Article
Advances in treatment for geographic atrophy

Advances in treatment for geographic atrophy

David S. Boyer, MD;Tina Mac Donald, OD, CDCES, FAAO;Leo P. Semes, OD, FAAO
October 11th 2023
Podcast
FDA accepts sBLA for Eylea HD for priority review by FDA - Image credit: ©Milos—stock.adobe.com

Regeneron’s sBLA for Eylea HD accepted for priority review by FDA

Martin David Harp, Editor, Ophthalmology Times
April 17th 2025
Article
Opus Genetics issues 1-month pediatric gene therapy results - Image credit: Adobe Stock / ©Andrii Yalanskyi

Opus Genetics issues 1-month pediatric gene therapy results

Lynda Charters
April 9th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.